Gaisford Simon, Verma Amit, Saunders Mark, Royall Paul G
Department of Pharmaceutics, School of Pharmacy, University of London, London, UK.
Int J Pharm. 2009 Oct 1;380(1-2):105-11. doi: 10.1016/j.ijpharm.2009.07.006. Epub 2009 Jul 22.
The aim of this study was to evaluate the potential of isothermal calorimetry to monitor and characterize crystallisation in drug-loaded fast-dissolving oral films. Films of polyvinylpyrrolidone (PVP) containing indomethacin were cast into glass ampoules; stability was assessed by monitoring the power changes occurring with time. Three grades of PVP (K10, K25 and K40, where the number multiplied by 1000 gives the average molecular weight) were used. Indomethacin was seen to crystallise from all PVP grades over ca. 24-48 h at two study temperatures (25 and 37 degrees C), as denoted by a large exothermic event. At 25 degrees C the exothermic event was a single peak; at 37 degrees C two peaks were observed. Subsequent analysis of the crystals with differential scanning calorimetry (DSC) and polarized light microscopy determined that the stable gamma-polymorph of indomethacin formed at 25 degrees C while both the gamma- and metastable alpha-polymorphs formed at 37 degrees C. The calorimetric data were converted to relative crystallinity as a function of time and analysed with three crystallisation models (Avrami, Tobin and Urbanovici-Segal) to determine crystallisation kinetics. Of the three models applied the Urbanovici-Segal model best described the data, although this may be because this model contains a term that effectively accounts for deviation from the Avrami model. The rate constants determined were broadly consistent irrespective of the model used. Increasing polymer molecular weight did not generally affect the crystallisation rate, although an increase in temperature did result in a concomitant increase in crystallisation rate. The data suggest that isothermal calorimetry is able to monitor drug crystallisation in polymer films and therefore the technique could be a useful tool for conducting stability assays for fast-dissolving oral medicines.
本研究的目的是评估等温滴定量热法监测和表征载药速溶口腔膜中结晶过程的潜力。将含有吲哚美辛的聚乙烯吡咯烷酮(PVP)膜浇铸到玻璃安瓿中;通过监测随时间发生的功率变化来评估稳定性。使用了三种等级的PVP(K10、K25和K40,其中数字乘以1000即为平均分子量)。在两个研究温度(25和37摄氏度)下,约24 - 48小时内,吲哚美辛从所有等级的PVP中结晶,表现为一个大的放热事件。在25摄氏度时,放热事件为单峰;在37摄氏度时,观察到两个峰。随后用差示扫描量热法(DSC)和偏光显微镜对晶体进行分析,确定在25摄氏度时形成了吲哚美辛稳定的γ - 多晶型,而在37摄氏度时形成了γ - 和亚稳的α - 多晶型。将量热数据转换为相对结晶度作为时间的函数,并使用三种结晶模型(阿弗拉米、托宾和乌尔巴诺维奇 - 西格尔)进行分析以确定结晶动力学。在所应用的三个模型中,乌尔巴诺维奇 - 西格尔模型对数据的描述最佳,不过这可能是因为该模型包含一个有效解释与阿弗拉米模型偏差的项。无论使用何种模型,所确定的速率常数大致一致。聚合物分子量的增加通常不会影响结晶速率,尽管温度升高确实会导致结晶速率随之增加。数据表明等温滴定量热法能够监测聚合物膜中的药物结晶,因此该技术可能是进行速溶口服药物稳定性测定的有用工具。